Entwicklung estrogenrezeptoraffiner cytotoxischer 1.1.2-Triphenylbut-1-ene:
Gespeichert in:
| 1. Verfasser: | |
|---|---|
| Format: | Abschlussarbeit Buch |
| Sprache: | German |
| Veröffentlicht: |
1986
|
| Schlagworte: | |
| Beschreibung: | 149 S. |
Internformat
MARC
| LEADER | 00000nam a2200000 c 4500 | ||
|---|---|---|---|
| 001 | BV000491284 | ||
| 003 | DE-604 | ||
| 005 | 19960703 | ||
| 007 | t | ||
| 008 | 870612s1986 m||| 00||| ger d | ||
| 035 | |a (OCoLC)255972691 | ||
| 035 | |a (DE-599)BVBBV000491284 | ||
| 040 | |a DE-604 |b ger |e rakddb | ||
| 041 | 0 | |a ger | |
| 049 | |a DE-12 |a DE-91 |a DE-29T |a DE-83 |a DE-11 |a DE-188 | ||
| 084 | |a VS 5075 |0 (DE-625)147684: |2 rvk | ||
| 100 | 1 | |a Schuderer, Michael |e Verfasser |4 aut | |
| 245 | 1 | 0 | |a Entwicklung estrogenrezeptoraffiner cytotoxischer 1.1.2-Triphenylbut-1-ene |c Michael Schuderer |
| 264 | 1 | |c 1986 | |
| 300 | |a 149 S. | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b n |2 rdamedia | ||
| 338 | |b nc |2 rdacarrier | ||
| 502 | |a Regensburg, Univ., Diss. | ||
| 650 | 7 | |a Brustkrebs |2 swd | |
| 650 | 7 | |a Chemische Affinität |2 swd | |
| 650 | 7 | |a Chemotherapie |2 swd | |
| 650 | 7 | |a Cytostatikum |2 swd | |
| 650 | 7 | |a Cytotoxizität |2 swd | |
| 650 | 7 | |a Triphenylbutene |2 swd | |
| 650 | 7 | |a Östrogenrezeptor |2 swd | |
| 650 | 0 | 7 | |a Cytostatikum |0 (DE-588)4068347-3 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Cytotoxizität |0 (DE-588)4193696-6 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Östrogenrezeptor |0 (DE-588)4172467-7 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Chemotherapie |0 (DE-588)4127083-6 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Brustkrebs |0 (DE-588)4008528-4 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Triphenylbutene |0 (DE-588)4386025-4 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Chemische Affinität |0 (DE-588)4132311-7 |2 gnd |9 rswk-swf |
| 655 | 7 | |0 (DE-588)4113937-9 |a Hochschulschrift |2 gnd-content | |
| 689 | 0 | 0 | |a Cytostatikum |0 (DE-588)4068347-3 |D s |
| 689 | 0 | 1 | |a Brustkrebs |0 (DE-588)4008528-4 |D s |
| 689 | 0 | |5 DE-604 | |
| 689 | 1 | 0 | |a Brustkrebs |0 (DE-588)4008528-4 |D s |
| 689 | 1 | 1 | |a Chemotherapie |0 (DE-588)4127083-6 |D s |
| 689 | 1 | |5 DE-604 | |
| 689 | 2 | 0 | |a Östrogenrezeptor |0 (DE-588)4172467-7 |D s |
| 689 | 2 | 1 | |a Chemische Affinität |0 (DE-588)4132311-7 |D s |
| 689 | 2 | 2 | |a Cytostatikum |0 (DE-588)4068347-3 |D s |
| 689 | 2 | |5 DE-604 | |
| 689 | 3 | 0 | |a Triphenylbutene |0 (DE-588)4386025-4 |D s |
| 689 | 3 | 1 | |a Cytotoxizität |0 (DE-588)4193696-6 |D s |
| 689 | 3 | 2 | |a Brustkrebs |0 (DE-588)4008528-4 |D s |
| 689 | 3 | |5 DE-604 | |
| 940 | 1 | |q TUB-nvmb | |
| 999 | |a oai:aleph.bib-bvb.de:BVB01-000303648 | ||
Datensatz im Suchindex
| _version_ | 1804114944680001536 |
|---|---|
| any_adam_object | |
| author | Schuderer, Michael |
| author_facet | Schuderer, Michael |
| author_role | aut |
| author_sort | Schuderer, Michael |
| author_variant | m s ms |
| building | Verbundindex |
| bvnumber | BV000491284 |
| classification_rvk | VS 5075 |
| ctrlnum | (OCoLC)255972691 (DE-599)BVBBV000491284 |
| discipline | Chemie / Pharmazie |
| format | Thesis Book |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>02206nam a2200625 c 4500</leader><controlfield tag="001">BV000491284</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">19960703 </controlfield><controlfield tag="007">t</controlfield><controlfield tag="008">870612s1986 m||| 00||| ger d</controlfield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)255972691</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV000491284</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rakddb</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">ger</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-12</subfield><subfield code="a">DE-91</subfield><subfield code="a">DE-29T</subfield><subfield code="a">DE-83</subfield><subfield code="a">DE-11</subfield><subfield code="a">DE-188</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">VS 5075</subfield><subfield code="0">(DE-625)147684:</subfield><subfield code="2">rvk</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Schuderer, Michael</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Entwicklung estrogenrezeptoraffiner cytotoxischer 1.1.2-Triphenylbut-1-ene</subfield><subfield code="c">Michael Schuderer</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">1986</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">149 S.</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="502" ind1=" " ind2=" "><subfield code="a">Regensburg, Univ., Diss.</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Brustkrebs</subfield><subfield code="2">swd</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Chemische Affinität</subfield><subfield code="2">swd</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Chemotherapie</subfield><subfield code="2">swd</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Cytostatikum</subfield><subfield code="2">swd</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Cytotoxizität</subfield><subfield code="2">swd</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Triphenylbutene</subfield><subfield code="2">swd</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Östrogenrezeptor</subfield><subfield code="2">swd</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Cytostatikum</subfield><subfield code="0">(DE-588)4068347-3</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Cytotoxizität</subfield><subfield code="0">(DE-588)4193696-6</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Östrogenrezeptor</subfield><subfield code="0">(DE-588)4172467-7</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Chemotherapie</subfield><subfield code="0">(DE-588)4127083-6</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Brustkrebs</subfield><subfield code="0">(DE-588)4008528-4</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Triphenylbutene</subfield><subfield code="0">(DE-588)4386025-4</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Chemische Affinität</subfield><subfield code="0">(DE-588)4132311-7</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="655" ind1=" " ind2="7"><subfield code="0">(DE-588)4113937-9</subfield><subfield code="a">Hochschulschrift</subfield><subfield code="2">gnd-content</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">Cytostatikum</subfield><subfield code="0">(DE-588)4068347-3</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="1"><subfield code="a">Brustkrebs</subfield><subfield code="0">(DE-588)4008528-4</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="689" ind1="1" ind2="0"><subfield code="a">Brustkrebs</subfield><subfield code="0">(DE-588)4008528-4</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2="1"><subfield code="a">Chemotherapie</subfield><subfield code="0">(DE-588)4127083-6</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="689" ind1="2" ind2="0"><subfield code="a">Östrogenrezeptor</subfield><subfield code="0">(DE-588)4172467-7</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="2" ind2="1"><subfield code="a">Chemische Affinität</subfield><subfield code="0">(DE-588)4132311-7</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="2" ind2="2"><subfield code="a">Cytostatikum</subfield><subfield code="0">(DE-588)4068347-3</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="2" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="689" ind1="3" ind2="0"><subfield code="a">Triphenylbutene</subfield><subfield code="0">(DE-588)4386025-4</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="3" ind2="1"><subfield code="a">Cytotoxizität</subfield><subfield code="0">(DE-588)4193696-6</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="3" ind2="2"><subfield code="a">Brustkrebs</subfield><subfield code="0">(DE-588)4008528-4</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="3" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="940" ind1="1" ind2=" "><subfield code="q">TUB-nvmb</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-000303648</subfield></datafield></record></collection> |
| genre | (DE-588)4113937-9 Hochschulschrift gnd-content |
| genre_facet | Hochschulschrift |
| id | DE-604.BV000491284 |
| illustrated | Not Illustrated |
| indexdate | 2024-07-09T15:14:46Z |
| institution | BVB |
| language | German |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-000303648 |
| oclc_num | 255972691 |
| open_access_boolean | |
| owner | DE-12 DE-91 DE-BY-TUM DE-29T DE-83 DE-11 DE-188 |
| owner_facet | DE-12 DE-91 DE-BY-TUM DE-29T DE-83 DE-11 DE-188 |
| physical | 149 S. |
| psigel | TUB-nvmb |
| publishDate | 1986 |
| publishDateSearch | 1986 |
| publishDateSort | 1986 |
| record_format | marc |
| spelling | Schuderer, Michael Verfasser aut Entwicklung estrogenrezeptoraffiner cytotoxischer 1.1.2-Triphenylbut-1-ene Michael Schuderer 1986 149 S. txt rdacontent n rdamedia nc rdacarrier Regensburg, Univ., Diss. Brustkrebs swd Chemische Affinität swd Chemotherapie swd Cytostatikum swd Cytotoxizität swd Triphenylbutene swd Östrogenrezeptor swd Cytostatikum (DE-588)4068347-3 gnd rswk-swf Cytotoxizität (DE-588)4193696-6 gnd rswk-swf Östrogenrezeptor (DE-588)4172467-7 gnd rswk-swf Chemotherapie (DE-588)4127083-6 gnd rswk-swf Brustkrebs (DE-588)4008528-4 gnd rswk-swf Triphenylbutene (DE-588)4386025-4 gnd rswk-swf Chemische Affinität (DE-588)4132311-7 gnd rswk-swf (DE-588)4113937-9 Hochschulschrift gnd-content Cytostatikum (DE-588)4068347-3 s Brustkrebs (DE-588)4008528-4 s DE-604 Chemotherapie (DE-588)4127083-6 s Östrogenrezeptor (DE-588)4172467-7 s Chemische Affinität (DE-588)4132311-7 s Triphenylbutene (DE-588)4386025-4 s Cytotoxizität (DE-588)4193696-6 s |
| spellingShingle | Schuderer, Michael Entwicklung estrogenrezeptoraffiner cytotoxischer 1.1.2-Triphenylbut-1-ene Brustkrebs swd Chemische Affinität swd Chemotherapie swd Cytostatikum swd Cytotoxizität swd Triphenylbutene swd Östrogenrezeptor swd Cytostatikum (DE-588)4068347-3 gnd Cytotoxizität (DE-588)4193696-6 gnd Östrogenrezeptor (DE-588)4172467-7 gnd Chemotherapie (DE-588)4127083-6 gnd Brustkrebs (DE-588)4008528-4 gnd Triphenylbutene (DE-588)4386025-4 gnd Chemische Affinität (DE-588)4132311-7 gnd |
| subject_GND | (DE-588)4068347-3 (DE-588)4193696-6 (DE-588)4172467-7 (DE-588)4127083-6 (DE-588)4008528-4 (DE-588)4386025-4 (DE-588)4132311-7 (DE-588)4113937-9 |
| title | Entwicklung estrogenrezeptoraffiner cytotoxischer 1.1.2-Triphenylbut-1-ene |
| title_auth | Entwicklung estrogenrezeptoraffiner cytotoxischer 1.1.2-Triphenylbut-1-ene |
| title_exact_search | Entwicklung estrogenrezeptoraffiner cytotoxischer 1.1.2-Triphenylbut-1-ene |
| title_full | Entwicklung estrogenrezeptoraffiner cytotoxischer 1.1.2-Triphenylbut-1-ene Michael Schuderer |
| title_fullStr | Entwicklung estrogenrezeptoraffiner cytotoxischer 1.1.2-Triphenylbut-1-ene Michael Schuderer |
| title_full_unstemmed | Entwicklung estrogenrezeptoraffiner cytotoxischer 1.1.2-Triphenylbut-1-ene Michael Schuderer |
| title_short | Entwicklung estrogenrezeptoraffiner cytotoxischer 1.1.2-Triphenylbut-1-ene |
| title_sort | entwicklung estrogenrezeptoraffiner cytotoxischer 1 1 2 triphenylbut 1 ene |
| topic | Brustkrebs swd Chemische Affinität swd Chemotherapie swd Cytostatikum swd Cytotoxizität swd Triphenylbutene swd Östrogenrezeptor swd Cytostatikum (DE-588)4068347-3 gnd Cytotoxizität (DE-588)4193696-6 gnd Östrogenrezeptor (DE-588)4172467-7 gnd Chemotherapie (DE-588)4127083-6 gnd Brustkrebs (DE-588)4008528-4 gnd Triphenylbutene (DE-588)4386025-4 gnd Chemische Affinität (DE-588)4132311-7 gnd |
| topic_facet | Brustkrebs Chemische Affinität Chemotherapie Cytostatikum Cytotoxizität Triphenylbutene Östrogenrezeptor Hochschulschrift |
| work_keys_str_mv | AT schuderermichael entwicklungestrogenrezeptoraffinercytotoxischer112triphenylbut1ene |